Related Experiment Video
Updated: May 13, 2026

Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR
Published on: July 11, 2025
Two-period, two-treatment crossover designs subject to non-ignorable missing data
John N S Matthews1, Robin Henderson
1School of Mathematics and Statistics, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
Missing data in crossover trials can bias treatment effects. This study shows the conventional AB/BA design is robust, but AB, BA, AA, BB designs may be better if dropout depends on response differences.
Area of Science:
- Biostatistics
- Clinical Trial Design
Background:
- Missing data is a common issue in crossover trials, potentially causing loss of efficiency or inestimability of contrasts.
- Existing designs have not adequately addressed bias introduced by the missingness process itself.
Purpose of the Study:
- To investigate the impact of non-ignorable missing data on treatment effect bias in two-treatment, two-period crossover designs.
- To assess the robustness of standard analysis methods under missing at random assumptions when data are non-ignorably missing.
Main Methods:
- Analysis of two-treatment, two-period crossover designs under missing data scenarios.
- Evaluation of the conventional AB/BA design and designs including AA and BB sequences.
- Comparison of robustness under missing at random versus non-ignorably missing data.
Main Results:
- The conventional AB/BA design demonstrates good robustness properties even with non-ignorable missing data.
- Designs incorporating sequences AB, BA, AA, and BB may offer advantages when dropout is related to response differences between periods.
Conclusions:
- The choice of crossover design impacts the potential for bias due to non-ignorable missing data.
- Careful consideration of the missingness mechanism is crucial for selecting robust crossover trial designs.
Related Concept Videos
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Comparing the Survival Analysis of Two or More Groups
Group Design
Censoring Survival Data
